Objective: Gastric cancer is a common malignancy worldwide. Effective treatment by interdisciplinary cooperation is important, and surgery still plays an important role. Material and Methods: In a ten-year period, 355 patients were diagnosed to have gastric cancer. One hundred and sixty-two patients with a median (range) age of 58 (23-83) years were eligible for the study. There were 107 patients in D2 and 55 patients in D2 lymphadenectomy plus para-aortic lymph node (PALN) dissection group. The two groups were compared in terms of complications, morbidity, mortality and long-term survival. Results: Length of stay was 12 (8-34) days for D2 and 14 (8-42) days for D2 plus PALND. Total number of operative mortality was 8/162 (5%), and it was not different between the groups. Twenty patients (18%) had complications in D2 group and 9 (17%) patients in D2 plus PALND group. Overall survival was also similar between the groups, but patients with T3-T4 tumors, patients with stage IIIA and IIIB disease had better survival with D2 plus PALN dissection. We found that the depth of invasion, PLN, ratio (PLN/TLN), stage and LND were all prognostic variables. Conclusion: This study showed that D2 plus PALN dissection for advanced gastric cancer can be performed as safely as a standard D2 dissection by experienced surgeons without increasing postoperative morbidity and mortality. D2 plus PALN dissection should be preferred in the advanced stage of the disease (IIIA-IIIB) as it increases the rate of survival.
Excess adiposity causes at least 13 cancers, and metabolic bariatric surgery (MBS) is increasingly presented as cancer-preventive. We appraised the evidence linking obesity, intentional weight loss and cancer against the Bradford Hill viewpoints, integrating literature published up to October 2026, including the IFSO GRADE-based position statement and a Nordic cohort of 784,105 adults. The obesity–cancer association fulfils the criteria of strength, consistency, biological gradient, temporality and plausibility. After MBS, matched cohorts and meta-analyses consistently report a 20–35% lower incidence of obesity-associated cancers, most clearly for endometrial, ovarian and liver cancer, and the Nordic cohort confirmed a 19% reduction irrespective of age or sex. However, no randomised trial has measured cancer incidence after MBS, certainty is low to very low, and oesophageal, gastric, pancreatic and prostate cancers show neutral or unfavourable signals. Incretin therapy appears protective in observational data but neutral in randomised trials. For surgical oncologists, altered anatomy delays the diagnosis of upper gastrointestinal cancer and changes reconstructive options. The protective association is real, coherent and site-specific but not yet proven causal; it should be discussed as an additional benefit in eligible patients, never as a stand-alone indication.
Objective: HLA molecules and antigen presentation pathways are critical for interactions between tumor cells and T cells. Defects in these mechanisms during carcinogenesis enable immune evasion. Cancer stem cells (CSCs) contribute to recurrence and treatment resistance due to their tumorigenic capacity and resistance to conventional therapies. Targeting CSCs and restoring HLA expression may improve outcomes. This study aimed to evaluate antigen presentation components and HLA expression in pancreatic cancer and CSCs. Materials and Methods: In silico analyses assessed expression of 40 antigen presentation genes according to high and low levels of 10 CSC markers across two pancreatic cancer datasets. Survival analyses compared patients with mutated and unmutated antigen presentation genes. In vitro studies were performed using BxPC3 and CFPAC1 cell lines. CSC presence was determined using specific markers. Tumor spheres were generated, and CSC proportions, along with HLA-ABC and B2M expression, were analyzed in spheres and parental cells by flow cytometry. This study was supported by the Hacettepe University Scientific Research Projects Coordination Unit (No: 19477). Results: Differential expression of antigen presentation molecules was observed across CSC marker groups. NLRC5 expression was significantly reduced in groups with high CSC marker expression, including PROM1 (CD133), SOX2, CD24, and CD44 (p<0.05). Survival was higher in patients without mutations in antigen presentation genes, although not statistically significant (p=0.564; p=0.128). In vitro findings showed increased CSC proportions in spheroids, while B2M and HLA-ABC expression was significantly decreased (p<0.05). Conclusion: These findings indicate that impaired antigen presentation and reduced HLA expression contribute to immune evasion in pancreatic cancer and CSCs. Targeting key molecules in this pathway may improve treatment strategies and warrants further investigation. Keywords: Antigen presentation mechanism, HLA expression, cancer stem cell, pancreatic cancer
1 January 2013 in World Journal of Gastroenterology
This is a response letter to Verna E's comments regarding our previous manuscript published last year in the World Journal of Gastroenterology entitled "Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer", which evaluated the relationship between these expression levels and clinicopathological parameters (Ozmen F et al, World J Gastroenterology 2011; 17: 3220-3228). The mean values for lymphatic vessel endothelial hyaluronan receptor-1, CD44 and vascular endothelial growth factor receptor-3 expression (represented as 2(-ΔΔCt)) were 1.13, 1.24 and 1.17, respectively, suggesting an increase in gene expression in tumor tissue compared to normal tissue. Despite the increase in gene expression in the cancer tissues (2(-ΔΔCt) > 1), only some of the results reached statistical significance, which was thoroughly discussed in our paper. In the present letter, we report that his comments are flawed and result in confusion. Therefore, we herein provide more explanation regarding gene expression in gastric cancer. We hope that this letter will address Verna E's misunderstandings.